Treatment of mouse 4T1 breast cancer model

YN Yingjie Nie
JH Jiang He
HS Hidekazu Shirota
AT Anna L. Trivett
DY De Yang
DK Dennis M. Klinman
JO Joost J. Oppenheim
XC Xin Chen
ask Ask a question
Favorite

An antibody recognizing TNFR2 (TR75-54.7) and/or an antibody recognizing CD25 (PC61) were administered at 200 μg in 0.2 ml of PBS 3 days before the inoculation of 1 × 105 4T1 breast tumor cells in 0.1 ml of PBS per mouse subcutaneously injected into right mammary fat pads (thoracic No. 2 mammary glands) of recipient female Balb/c mice.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A